Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease. Qi X, Li J, Caussy C, Teng GJ, et al. Hepatology 2026;83:661-678.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Qi X, Li J, Caussy C, Teng GJ, et al. Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease. Hepatology 2026;83:661-678.
PMID: 38722246